Rhythm Pharmaceuticals, Inc. Gains 31.48%

Wed, Jul 13, 2022 at 08:33 PM
Rhythm Pharmaceuticals, Inc. Gains 31.48%

Rhythm Pharmaceuticals, Inc. (RYTM:NASDAQ) soared at $8.77, a gain of 31.5%. On Wed, Jul 13, 2022, RYTM:NASDAQ touched a New 2-Week High of $8.77. The stock appeared on our News Catalysts scanner on Wed, Jul 13, 2022 at 02:39 PM in the 'MISCELLANEOUS' category. From Wed, Jun 29, 2022, the stock recorded 77.78% Up Days and 70.00% Green Days

About Rhythm Pharmaceuticals, Inc. (RYTM:NASDAQ)

Rhythm Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders.

Share
Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.